Login or Sign Up
Remus Pharmaceuticals Ltd. Financials
15:40 Jun 19
Remus Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Remus Pharmaceuticals Ltd.
Industry Pharmaceuticals
15:40 Jun 19
Quality
0/100
Not Eligible
Valuation
23/100
Expensive Valuation
Technical
32/100
Technically Bearish
Strength
2
Weakness
4
Opportunity
0
Threats
0
11.36 %
ROE %
6.71 %
ROA %
49.34
EPS
434.40
BVPS
4.68 %
Net Profit Margin
| Mar 2024 | Mar 2025 | ||
|---|---|---|---|
| Net Sales | 212.5 | 620.36 | |
| Operating Expenses + | 184.69 | 574.67 | |
| Raw Material | 164.99 | 541.31 | |
| Increase Decrease in Cost | -0.67 | -8.44 | |
| Other Manufacturing Expense | 0 | 0 | |
| Employee Cost | 7.42 | 13.11 | |
| Miscellaneous Expenses | 342.93 | 1111.31 | |
| Operating Profit | 27.81 | 45.69 | |
| Other Income | 5.4 | 4.98 | |
| Depreciation | 0.9 | 1.87 | |
| Interest | 0.48 | 1.46 | |
| Profit before tax and exceptio.. | 31.83 | 47.34 | |
| Exceptional Items | 0 | 0 | |
| PBT | 31.83 | 47.34 | |
| Provision for Taxation | 5.85 | 8.92 | |
| Net Profit | 25.98 | 38.42 | |
| NET Profit after MI | 25.98 | 29.07 | |
| EPS | 152.01 | 65.21 | |
| Operating Profit Margin (%) | 13.09 | 7.37 | |
| Net Profit Margin (%) | 12.23 | 4.69 |
Remus Pharmaceuticals Ltd. Shareholding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Mar 25 | Sep 24 | Mar 24 | |
|---|---|---|---|
| Promoter | 70.80 | 70.80 | 70.60 |
| FII | 4.80 | 3.20 | 3.20 |
| MF | 0.00 | 0.00 | 0.00 |
| Others | 0.70 | 0.70 | 0.70 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
